Wall Street Zen Downgrades Lumexa Imaging (NASDAQ:LMRI) to Hold

Posted by Brian Himes on Aug 10th, 2026

Lumexa Imaging (NASDAQ:LMRI – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday.

A number of other analysts have also recently issued reports on LMRI. Weiss Ratings upgraded Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a report on Thursday, June 25th. Barclays cut their price target on shares of Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating on the stock in a report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Lumexa Imaging has a consensus rating of “Moderate Buy” and an average price target of $16.00.

Read Our Latest Stock Report on Lumexa Imaging

Lumexa Imaging Price Performance

LMRI stock opened at $11.58 on Friday. The company has a market cap of $1.11 billion and a PE ratio of -19.63. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.43. The stock has a 50-day moving average price of $10.45 and a two-hundred day moving average price of $10.99. Lumexa Imaging has a 12-month low of $6.45 and a 12-month high of $19.45.

Insider Buying and Selling

In related news, Director Brett Brodnax acquired 35,000 shares of Lumexa Imaging stock in a transaction on Tuesday, May 19th. The shares were bought at an average price of $7.25 per share, for a total transaction of $253,750.00. Following the completion of the purchase, the director directly owned 62,027 shares in the company, valued at $449,695.75. This trade represents a 129.50% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Lumexa Imaging

Several hedge funds have recently modified their holdings of the stock. Janus Henderson Group PLC boosted its holdings in Lumexa Imaging by 5.4% in the 1st quarter. Janus Henderson Group PLC now owns 2,100,356 shares of the company’s stock worth $18,063,000 after acquiring an additional 107,903 shares during the period. T. Rowe Price Investment Management Inc. purchased a new stake in shares of Lumexa Imaging during the fourth quarter valued at approximately $37,139,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in shares of Lumexa Imaging during the fourth quarter worth $27,750,000. ArrowMark Colorado Holdings LLC purchased a new position in shares of Lumexa Imaging in the fourth quarter valued at $27,750,000. Finally, Invesco Ltd. acquired a new stake in Lumexa Imaging during the 4th quarter valued at $26,562,000.

About Lumexa Imaging

(Get Free Report)

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).